NCT02232763View on ClinicalTrials.gov

Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria

PHASE3CompletedINTERVENTIONAL
Enrollment

58

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Proteinuria
Interventions
DRUG

Losartan

12 weeks of losartan or placebo with crossover to the other

DRUG

Placebo

12 weeks of losartan or placebo with crossover to the other

Trial Locations (1)

Unknown

Seoul National University Children's Hospital, Seoul

All Listed Sponsors
collaborator

Ministry of Food and Drug Safety, Korea

OTHER_GOV

lead

Seoul National University Hospital

OTHER

NCT02232763 - Efficacy and Safety of Losartan in Pediatric Chronic Kidney Disease With Tubular Proteinuria | Biotech Hunter | Biotech Hunter